Literature DB >> 1902824

HLA class II restriction of autoantibody production in patients with systemic lupus erythematosus.

H A Stephens1, N J McHugh, P J Maddison, D A Isenberg, K I Welsh, G S Panayi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1902824     DOI： 10.1007/bf00230506

Source DB:  PubMed          Journal:  Immunogenetics        ISSN： 0093-7711            Impact factor:   2.846


× No keyword cloud information.
  24 in total

1.  Epitope mapping with a recombinant human 68-kDa (U1) ribonucleoprotein antigen reveals heterogeneous autoantibody profiles in human autoimmune sera.

Authors:  H H Guldner; H J Netter; C Szostecki; H J Lakomek; H Will
Journal:  J Immunol       Date:  1988-07-15       Impact factor: 5.422

2.  A hypothetical model of the foreign antigen binding site of class II histocompatibility molecules.

Authors:  J H Brown; T Jardetzky; M A Saper; B Samraoui; P J Bjorkman; D C Wiley
Journal:  Nature       Date:  1988-04-28       Impact factor: 49.962

3.  HLA and immunoglobulin allotypes in mixed connective tissue disease.

Authors:  C M Black; P J Maddison; K I Welsh; R Bernstein; J C Woodrow; R S Pereira
Journal:  Arthritis Rheum       Date:  1988-01

Review 4.  Autoantibodies to nuclear antigens (ANA): their immunobiology and medicine.

Authors:  E M Tan
Journal:  Adv Immunol       Date:  1982       Impact factor: 3.543

5.  Interrelationships of HLA-DR, MB, and MT phenotypes, autoantibody expression, and clinical features in systemic lupus erythematosus.

Authors:  J M Ahearn; T T Provost; C A Dorsch; M B Stevens; W B Bias; F C Arnett
Journal:  Arthritis Rheum       Date:  1982-09

6.  Are snRNPs involved in splicing?

Authors:  M R Lerner; J A Boyle; S M Mount; S L Wolin; J A Steitz
Journal:  Nature       Date:  1980-01-10       Impact factor: 49.962

7.  Serologic subsets in systemic lupus erythematosus: an examination of autoantibodies in relationship to clinical features of disease and HLA antigens.

Authors:  D A Bell; P J Maddison
Journal:  Arthritis Rheum       Date:  1980-11

8.  Anti La(SSB) identifies a distinctive subgroup of systemic lupus erythematosus.

Authors:  P J Maddison; D A Isenberg; N J Goulding; J Leddy; R P Skinner
Journal:  Br J Rheumatol       Date:  1988-02

9.  Family study of the major histocompatibility complex in patients with systemic lupus erythematosus: importance of null alleles of C4A and C4B in determining disease susceptibility.

Authors:  A H Fielder; M J Walport; J R Batchelor; R I Rynes; C M Black; I A Dodi; G R Hughes
Journal:  Br Med J (Clin Res Ed)       Date:  1983-02-05

10.  DNA typing of HLA-DR antigens in systemic lupus erythematosus.

Authors:  H Dunckley; P A Gatenby; S W Serjeantson
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846
View more
  3 in total

Review 1.  Antinuclear antibodies to RNA-binding proteins in SLE.

Authors:  P J Maddison
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

2.  Analysis of HLA-DR and -DQ gene polymorphisms in Sudanese patients with type 1 (insulin-dependent) diabetes.

Authors:  M M Magzoub; H A Stephens; E A Gale; G F Bottazzo
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

3.  The spliceosomal autoantigen heterogeneous nuclear ribonucleoprotein A2 (hnRNP-A2) is a major T cell autoantigen in patients with systemic lupus erythematosus.

Authors:  Ruth Fritsch-Stork; Daniela Müllegger; Karl Skriner; Beatrice Jahn-Schmid; Josef S Smolen; Günter Steiner
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.